TARO Feb 21
Taro Pharmaceuticals Reports Record 2001 Results --
24 Consecutive Quarters of Record Sales,
14 Consecutive Quarters of Record Net Income
Business Editors
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Feb. 21, 2002--Taro
Pharmaceutical Industries Ltd. (NASDAQ/NMS: TARO)--
2001 Highlights
- Q4 Sales Increase 47% to $44,013,000
- Q4 Gross Profit Increases 58% to $28,459,000
- Q4 Net Income Increases 180% to $9,826,000, or $0.34 per
Diluted Share
- 2001 Sales Increase 45% to $150,134,000
- 2001 Net Income Increases 159% to $25,994,000, or $0.99 per
Diluted Share
- Taro Closed Public Offering of 5,750,000 Ordinary Shares in Q4
2001
Taro Pharmaceutical Industries Ltd. (NASDAQ/NMS: TARO) today
reported record fourth quarter and year end results.
Fred |
